Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations: Results From the TAPUR Study - Gupta, R; Meric-Bernstam, F; Rothe, M (JCO Precis Oncol, 2022)